Rheumatologist, research in Myositis & Interstitial lung disease, medical director, Myositis Center, Professor of Medicine, @UPMC @pittrheum
Pittsburgh, PA
Joined December 2013
- Tweets1K
- Following4K
- Followers5.9K
- Likes411
Join today to hear complex cases of myositis and management from @Myositis_India at 8 am EST. Register below !
Exciting initiative by @MyositisIndia!
Enigmatic Case Presentation Competition 2026 – Part I
with 14 shortlisted presenters.
📅 Oct 18 | 5:30 PM IST | Virtual
Join rheumatologists, fellows & trainees!
Register: forms.gle/a6pk7sz9FXSjifkp8
#Rheumatology #Myositis #MyositisIndia
Myositis patients - Please consider to join this global research endeavor on myositis ! No travel or visits needed. This a simple survey study.
Living with myositis? Join global research from your phone 🌍
My PACER Study (Univ of Pittsburgh) is 100% remote. No clinic visits, just a short questionnaire every 6 months via the MyCap app.
Open to adults with myositis - mypacerstudy.org
#Myositis #RareDisease
Exciting initiative by @MyositisIndia!
Enigmatic Case Presentation Competition 2026 – Part I
with 14 shortlisted presenters.
📅 Oct 18 | 5:30 PM IST | Virtual
Join rheumatologists, fellows & trainees!
Register: forms.gle/a6pk7sz9FXSjifkp8
#Rheumatology #Myositis #MyositisIndia
Missed her picture
Delighted to announce that Dr. Zechen Ma has joined UPMC’s Myositis Fellowship Program for 2026-2027! With training from McMaster, Alberta, and Toronto, she brings a strong clinical foundation. We look forward to supporting her in advancing myositis care.
#Myositis #Rheumatology
Delighted to announce that Dr. Zechen Ma has joined UPMC’s Myositis Fellowship Program for 2026-2027! With training from McMaster, Alberta, and Toronto, she brings a strong clinical foundation. We look forward to supporting her in advancing myositis care.
#Myositis #Rheumatology
Looking forward to MCTC CAR-T webinar @MctcMyositis
Join us for “Latest Advances in CAR T-Cell Therapy for Inflammatory Myopathies,” featuring Dr. Vikas Majithia and moderated by Dr. Mathilde Bandeira.
📅 September 25, 2026
⏰ 10 AM ET
🔗 lnkd.in/eZH-WTq9
#Myositis #CAR
🚨#Myositis Breaking News: FDA approves the 1st-ever oral targeted therapy for #Dermatomyositis — brepocitinib (Lisraya), a JAK1/TYK2 inhibitor. With Brepo + IVIG now approved, it’s time to reduce our reliance on long-term steroids. Big step forward ! 🎉 fda.gov/news-events/press-an…
Novel tx for Myositis : After IVIG (ProDERM by Octapharma) & Brepocitinib (Valor by Priovant) in DM, for the first time we have highly positive phase 3 trial for IMNM & DM. Efgartogimod SQ (anti-FcRN) showed significant improvement in IMNM & DM vs. PBO.
argenx.com/news/2026/press-r…
MCTC Webinar: CAR-T Cell Therapy Advances in Inflammatory Myopathies
Join Dr. Vikas Majithia (Mayo Clinic Jacksonville) one with most experience in CAR-T, moderated by Dr. Matilde Bandeira, for the research updates.
📅 Sept. 25, 2026 | 10 AM EST
#CART #Myositis #MCTC #Research xitter.cf/docrota/status/2082210…
🧠 Living with myositis?
You can help advance research-right from your phone, anywhere in the world
Join My PACER Registry, a global myositis study by the University of Pittsburgh.
🔗 mypacerstudy.org
#Myositis #Dermatomyositis #Polymyositis #MyositisResearch #RareDisease
Myositis India invites MD/DNB/DM/DrNB trainees to participate in the Enigmatic Case Presentation Competition 2026. Submit a 300-word abstract on an interesting myositis-related case. Winners will be felicitated at IRACON 2026. Deadline: 15 Jul 2026. #MyositisIndia #IRACON2026
Medical trainees, present your interesting myositis case before the Stalwarts of Rheumatology!
Myositis India invites submissions for the 2026 Enigmatic Case Presentation Competition.
Open to MD, DNB, DM & DrNB trainees.
Deadline: 15-07-2026
Email: [email protected]
Rohit Aggarwal retweeted
#PatientStories
Meet Mr Prashant Varma, our braveheart volunteer, diagnosed with myositis in 2020 after visiting multiple doctors. For him, finally getting a diagnosis was bittersweet.
Register: myositisindia.org/register
Donate: myositisindia.org/donate
#MyositisIndia @docrota
Rohit Aggarwal retweeted
This Myositis Awareness Month, we share the inspiring journey of our ambassador @Samanthaprabhu2 , who faced Myositis with courage and continues to inspire patients, caregivers, & supporters.
@Myositis_India is here for you at every step.
Donate: myositisindia.org/donate
@docrota
Join Myositis India for the Physician Webinar on “Interferons in IIM” on 31 May 2026 | 8 PM IST.
Featuring Dr. Akira Yoshida & Dr. Rudrarpan Chatterjee.
Register here: forms.gle/Z3nP1czznbnL1Q3f7
#Myositis #Rheumatology #IIM
One voice can inspire thousands to feel seen, heard, & hopeful. More than an interview — a conversation that brings strength to the myositis community. Grateful to Samantha Ruth Prabhu a Bollywood star for using her voice to spread myositis awareness.
Rohit Aggarwal retweeted
Wishing Samantha Ruth Prabhu (@Samanthaprabhu2) a very Happy Birthday! 🎂💙
Her courage in openly sharing her myositis journey has been a beacon of hope for countless patients across India. Today, the entire myositis community comes together to celebrate her strength, resilience, and the powerful voice she lends to our cause. Your strength gives us hope. Your voice helps us be heard. 🌿
#HappyBirthdaySamantha #MyositisIndia #StrengthSupportAwareness #SamanthaRuthPrabhu
The most exciting news ever for myositis pts: a novel oral JAK1/TYK2 inhibitor (brepocitinib) shows positive Phase 3 results in dermatomyositis. Honored to part of the VALOR & NEJM- grateful to our patients, investigators, and Priovant. FDA Approval soon. nejm.org/doi/abs/10.1056/NEJ…
We are starting the webinar on clinical trials in Myositis for physicians in an hour (8.30 am EST US / 7 pm IST India).
Clinical trials aren’t optional in myositis, they’re the backbone of evidence-based care.
Join leading experts to discuss key challenges, barriers, and the way forward.
🗓 8 Feb 2026 | SUNDAY |⏰ 7 PM IST
📲 Register via QR
#Myositis #ClinicalTrials #Rheumatology
